Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
01/2003
01/23/2003WO2003006429A1 Synthesis of taxol enhancers
01/23/2003WO2003006428A1 Taxol enhancer compounds
01/23/2003WO2003006425A2 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
01/23/2003WO2003006424A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
01/23/2003WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
01/23/2003WO2003006040A1 Method for isolating terpene trilactones (ginkgolides, bilobalide) from leaves and pharmaceutical powders of ginkgo biloba
01/23/2003WO2002068402A3 Separation of 2,5-dihydrofuran and water from mixtures thereof by extractive distillation
01/23/2003WO2002055491A3 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a)
01/23/2003WO2002049413A3 Thrombopoietin mimetics
01/23/2003US20030018205 Catalytic hydrogenation of furfural to produce 2-methylfuran and 2-methyltetrahydrofuran, using a reduced copper based catalyst containing oxides of copper in cupric form, chromiumIII, manganese, and barium and a reduced nickel II
01/23/2003US20030018204 Halogen-containing aromatic acid dianhydride, halogen-containing aromatic tetranitrile compound, haltogen-containing aromatic tetracarbonxylic acid and halogen containing m-phenylenediamine compound
01/23/2003US20030018192 Preparation of substituted aromatic compounds
01/23/2003US20030018191 Process for the preparation of 3-arly-benzofuranones
01/23/2003US20030018067 Cardiovascular disorders; anticancer agents
01/23/2003US20030018062 Deacetylase inhibitors
01/23/2003US20030018013 Cardiovascular disorders; antilipemic agents; Alzheimer's disease
01/23/2003US20030017166 Combination preparation for the therapy of immunological diseases
01/23/2003US20030017095 Reactor having a heat exchange medium circulation
01/23/2003CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
01/23/2003CA2453467A1 Method for isolating terpene trilactones (ginkgolides, bilobalide) from leaves and pharmaceutical powders of ginkgo biloba
01/23/2003CA2453415A1 Synthesis of taxol enhancers
01/23/2003CA2453175A1 Interaction inhibitors of tcf-4 with beta-catenin
01/23/2003CA2452491A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
01/22/2003EP1277751A1 2- and 2,5-substituted phenylketo-enols
01/22/2003EP1277749A1 2- and 2,5-substituted phenylketo enols
01/22/2003EP1277748A1 Process for producing optically active y-Butyrolactone
01/22/2003EP1277747A1 Selective preventives/remedies for progressive lesions after organ damage
01/22/2003EP1277736A1 Novel bicyclic compounds
01/22/2003EP1277735A1 2- and 2,5-substituted phenylketo-enols
01/22/2003EP1277734A1 2- and 2,5-substituted phenylketo-enols
01/22/2003EP1277733A1 2- and 2,5-substituted phenylketo-enols
01/22/2003EP1276736A2 Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes
01/22/2003EP1165537B1 Hydroxymatairesinol in cancer prevention
01/22/2003EP1071660B1 N-sulphonyl and n-sulphinyl phenylglycinamide
01/22/2003EP1030838B1 Method of synthesis of pyrrole amides
01/22/2003EP0952978B1 Metallocenes and catalysts for olefin-polymerisation
01/22/2003EP0828728B1 Phenyl dihydrobenzofuranes
01/22/2003CN1099418C Tetrahydro-3-furanyl methylamine
01/22/2003CN1099417C New polycyclic 2,3-phthalazine derivatives and their use
01/22/2003CN1099413C Certain fused N-pyrrolylaniline: new class of GABA brain receptor ligand
01/22/2003CN1099284C Aryloxy propyl amine compound for treatment of incontinence of urine
01/21/2003US6509499 Nervous system disorders, vision defects, diabetic retinopathy, neuropathic pain and kidney disorder treatment
01/21/2003US6509483 Method for the preparation of citalopram
01/21/2003US6509481 Tetrahydrofuran compounds having alicyclic structure
01/21/2003US6509474 Method of lithiating five membered heterocycles
01/21/2003US6509360 Penyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
01/21/2003US6509354 3-arylphenyl sulfide derivative and insecticide and miticide
01/16/2003WO2003005025A1 Methods for identifying compounds modulating the activity of ppar-gamma
01/16/2003WO2003004485A1 Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof
01/16/2003WO2003004484A1 Novel aliphatic compounds, synthesis method and method of using the same
01/16/2003WO2003004483A1 Substituted $g(g)-lactone compounds serving as nmda antagonists
01/16/2003WO2003004480A2 Substituted piperazine and diazepanes as histamine h3 receptor agonists
01/16/2003WO2003004479A1 4-aryl quinols and analogs thereof as therapeutic agents
01/16/2003WO2003004458A1 New compounds
01/16/2003WO2002070467B1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments
01/16/2003WO2002046129A3 Inhibitors of histone deacetylase
01/16/2003WO2001072731A3 Enantioselective process for preparing arylated lactones and derivatives
01/16/2003US20030013898 Pericyte protective agent
01/16/2003US20030013895 Method for the preparation of 5-cyanophthalide
01/16/2003US20030013892 Production of chirally pure alpha-amino acids and N-sulfonyl alpha-amino acids
01/16/2003US20030013887 Substituted aromatic ethers as inhibitors of glycine transport
01/16/2003US20030013884 Compounds for use in 11-oxa prostaglandin synthesis
01/16/2003US20030013881 Such as 4-((6-(3,5-difluoro-phenyl)-5-(S)-(3-dipropylcarb-amoyl-benzoyl-amino)-2-(R)-ethyl-4-(S)-hydroxy-hexanoylamino)-methyl)-cyclohexanecarboxylic acid for inhibiting secretase activity and cleavage of amyloid precursor protein
01/16/2003US20030013758 Wound healing agents; brain disorders; cardiovascular disorders; sleep disorders
01/16/2003US20030013757 Aromatic dicarboxylic acid derivatives
01/16/2003US20030013755 Autoinducer compounds
01/16/2003US20030013751 Viricides; enzyme inhibitors
01/16/2003US20030013748 Anticancer agents
01/16/2003US20030013744 3,4-diaryl thiophenes and analogs thereof having use as anti-inflammatory agents
01/16/2003US20030013725 Amino acid derivatives
01/16/2003US20030013715 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
01/16/2003US20030013677 Anticancer agents
01/16/2003US20030013041 Write-once optical data carrier
01/16/2003CA2452592A1 4-aryl quinols and analogs thereof as therapeutic agents
01/15/2003EP1275638A1 Combination therapy for the treatment of immunological disorders
01/15/2003EP1275301A1 Trisubstituted heterocyclic compounds and their use as fungicides
01/15/2003EP1274980A1 Solution and crystal structures of mmp-13 active site and uses thereof
01/15/2003EP1274699A1 Method for the preparation of 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
01/15/2003EP1274424A1 Compounds and methods
01/15/2003EP0918765B1 Process for preparing phthalides
01/15/2003EP0915863B1 Dihydrofuran carboxamides
01/15/2003EP0713483B1 Amidine derivatives with nitric oxide synthetase activities
01/15/2003CN1391571A Heterocyclic compounds and their use as medicines
01/15/2003CN1391567A Preparation of 5-carboxyphthalide
01/15/2003CN1391566A Preparation of citalopram
01/15/2003CN1391565A Benzophenones as inhibitors of reverse transcriptase
01/15/2003CN1391473A VLA-4 inhibitor compounds
01/15/2003CN1391469A Npyy5拮抗剂 Npyy5 antagonist
01/15/2003CN1390822A Polyalkyl bicyclic derivative
01/15/2003CN1098847C Furan-and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of replication of HIV-1 and HIV-1 mutants
01/15/2003CN1098837C Serial-alkyl-1-alkoxy-1-alkylsulfonyl methane compounds and its preparing method
01/14/2003US6506876 LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
01/14/2003US6506863 Used as crosslinking agents for olefin polymers
01/14/2003US6506796 Cosmetically or therapeutically treating diseases or disorders in cell populations whose pathology is linked to an inadequate rate of apoptosis by administering a therapeutically effective amount of
01/14/2003US6506780 Benzophenones and sulfones as inhibitors of glycine uptake
01/14/2003US6506778 Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals
01/14/2003US6506517 Surface modified carbonaceous materials
01/14/2003US6506285 Syntheses of 5,5′-diformyl-2-2′difuran and derivatives thereof
01/09/2003WO2003002533A1 Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion
01/09/2003WO2003002532A1 Cyclic diamine compounds having fused-ring groups